Individualized neoantigen peptides vaccine (Tianjin Hengjia Biotechnology)

N/A

Report date: 2024/11/24 20:00:04

Base Information

Drug NameIndividualized neoantigen peptides vaccine (Tianjin Hengjia Biotechnology)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesTianjin Hengjia Biotechnology Development Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTianjin Hengjia Biotechnology Development Co LtdSun Yat-Sen University
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A